Abbott India [ABBOTINDIA] vs Pfizer [PFIZER] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Abbott India Ltd. wins in 11 metrics, Pfizer Ltd. wins in 9 metrics, with 0 ties. Abbott India Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Abbott India Ltd. | Pfizer Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 35.14 | 25.56 | Pfizer Ltd. |
| Price-to-Book Ratio | 13.34 | 5.66 | Pfizer Ltd. |
| Debt-to-Equity Ratio | 4.55 | 2.33 | Pfizer Ltd. |
| PEG Ratio | 8.36 | 2.28 | Pfizer Ltd. |
| EV/EBITDA | 28.54 | 22.48 | Pfizer Ltd. |
| Profit Margin (TTM) | 22.33% | 34.39% | Pfizer Ltd. |
| Operating Margin (TTM) | 25.79% | 33.17% | Pfizer Ltd. |
| EBITDA Margin (TTM) | 25.79% | 33.17% | Pfizer Ltd. |
| Return on Equity | 33.41% | 18.20% | Abbott India Ltd. |
| Return on Assets (TTM) | 23.90% | 15.63% | Abbott India Ltd. |
| Free Cash Flow (TTM) | $9.59B | $6.32B | Abbott India Ltd. |
| Dividend Yield | 1.41% | 1.27% | Abbott India Ltd. |
| 1-Year Return | -16.61% | -23.35% | Abbott India Ltd. |
| Price-to-Sales Ratio (TTM) | 7.84 | 8.78 | Abbott India Ltd. |
| Enterprise Value | $513.48B | $194.17B | Abbott India Ltd. |
| EV/Revenue Ratio | 7.53 | 7.82 | Abbott India Ltd. |
| Gross Profit Margin (TTM) | 47.29% | 65.15% | Pfizer Ltd. |
| Revenue per Share (TTM) | $3,211 | $543 | Abbott India Ltd. |
| Earnings per Share (Diluted) | $716.56 | $186.40 | Abbott India Ltd. |
| Beta (Stock Volatility) | 0.01 | 0.17 | Abbott India Ltd. |
Abbott India Ltd. vs Pfizer Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Abbott India Ltd. | -0.10% | 1.84% | -6.03% | -1.56% | -5.85% | -7.83% |
| Pfizer Ltd. | 0.20% | -0.22% | -8.81% | -4.87% | -9.94% | -8.09% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Abbott India Ltd. | -16.61% | 15.71% | 58.92% | 498.24% | 1,737.83% | 9,645.97% |
| Pfizer Ltd. | -23.35% | 16.94% | -16.55% | 139.64% | 232.33% | 479.18% |
Performance & Financial Health Analysis: Abbott India Ltd. vs Pfizer Ltd.
| Metric | ABBOTINDIA | PFIZER |
|---|---|---|
| Market Information | ||
| Market Cap | ₹535.06B | ₹218.82B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 14,225 | 14,470 |
| 90 Day Avg. Volume | 10,945 | 18,450 |
| Last Close | ₹26,255.00 | ₹4,518.00 |
| 52 Week Range | ₹25,150.00 - ₹37,000.00 | ₹4,396.70 - ₹5,993.00 |
| % from 52W High | -29.04% | -24.61% |
| All-Time High | ₹37,000.00 (Jun 27, 2025) | ₹6,451.15 (Sep 02, 2024) |
| % from All-Time High | -29.04% | -29.97% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.07% | 0.20% |
| Quarterly Earnings Growth | 0.04% | 0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.22% | 0.34% |
| Operating Margin (TTM) | 0.26% | 0.33% |
| Return on Equity (TTM) | 0.33% | 0.18% |
| Debt to Equity (MRQ) | 4.55 | 2.33 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹1,887.48 | ₹841.24 |
| Cash per Share (MRQ) | ₹1,102.27 | ₹591.12 |
| Operating Cash Flow (TTM) | ₹13.36B | ₹9.08B |
| Levered Free Cash Flow (TTM) | ₹14.14B | ₹7.68B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.41% | 1.27% |
| Last 12-Month Dividend | ₹475.00 | ₹70.00 |
Valuation & Enterprise Metrics Analysis: Abbott India Ltd. vs Pfizer Ltd.
| Metric | ABBOTINDIA (Apr 26, 2026) | PFIZER (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 35.14 | 25.56 |
| Forward P/E | 31.06 | 25.15 |
| PEG Ratio | 8.36 | 2.28 |
| Price to Sales (TTM) | 7.84 | 8.78 |
| Price to Book (MRQ) | 13.34 | 5.66 |
| Market Capitalization | ||
| Market Capitalization | ₹535.06B | ₹218.82B |
| Enterprise Value | ₹513.48B | ₹194.17B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.53 | 7.82 |
| Enterprise to EBITDA | 28.54 | 22.48 |
| Risk & Other Metrics | ||
| Beta | 0.01 | 0.17 |
| Book Value per Share (MRQ) | ₹1,887.48 | ₹841.24 |
Financial Statements Comparison: Abbott India Ltd. vs Pfizer Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ABBOTINDIA (2025) | PFIZER (2025) |
|---|---|---|
| Revenue/Sales | 64.07B | 22.81B |
| Cost of Goods Sold | 35.11B | 8.13B |
| COGS % of Revenue | 54.8% | 35.6% |
| Gross Profit | 28.96B | 14.68B |
| Gross Margin | 45.2% | 64.4% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | 16.45B | 6.81B |
| Operating Margin | 25.7% | 29.9% |
| EBITDA | 19.75B | 9.13B |
| EBITDA Margin | 30.8% | 40.0% |
| Pre-Tax Income | 18.87B | 10.16B |
| Pre-Tax Income % of Revenue | 29.5% | 44.5% |
| Income Tax | 4.73B | 2.48B |
| Income Tax % of Revenue | 7.4% | 10.9% |
| Net Income (Profit) | 14.14B | 7.68B |
| Profit Margin | 22.1% | 33.7% |
Balance Sheet & Liquidity Metrics
| Metric | ABBOTINDIA (2025) | PFIZER (2025) |
|---|---|---|
| Cash & Equivalents | 5.61B | 4.95B |
| Total Current Assets | 47.65B | 35.13B |
| Total Current Assets % of Revenue | 74.4% | 154.0% |
| Total Current Liabilities | 14.07B | 5.70B |
| Total Current Liabilities % of Revenue | 22.0% | 25.0% |
| Long-Term Debt | 1.58B | 676.20M |
| Long-Term Debt % of Revenue | 2.5% | 3.0% |
| Total Shareholders Equity | 42.33B | 42.17B |
| Retained Earnings | 32.21B | 24.36B |
| Retained Earnings % of Revenue | 50.3% | 106.8% |
| Property, Plant & Equipment | 3.30B | 1.72B |
Cash Flow Statement Comparison
| Metric | ABBOTINDIA (2025) | PFIZER (2025) |
|---|---|---|
| Operating Cash Flow | 13.36B | 9.08B |
| Operating Cash Flow % of Revenue | 20.9% | 39.8% |
| Capital Expenditures | -520.80M | 1.24B |
| Free Cash Flow | 9.59B | 6.32B |
| FCF Margin | 15.0% | 27.7% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ABBOTINDIA | PFIZER |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 21.25M | 45.75M |
| Float Shares | 5.19M | 15.10M |
| % Held by Insiders | 75.56% | 66.98% |
| % Held by Institutions | 7.81% | 16.80% |
| % Held by Public | 16.63% | 16.22% |
Dividend Analysis & Yield Comparison: Abbott India Ltd. vs Pfizer Ltd.
| Metric | ABBOTINDIA | PFIZER |
|---|---|---|
| Last 12-Month Dividend | ₹475.00 | ₹70.00 |
| Last 12-Month Dividend Yield | 1.41% | 1.27% |
| 3-Year Avg Annual Dividend | ₹451.67 | ₹46.67 |
| 3-Year Avg Dividend Yield | 0.99% | 0.58% |
| 3-Year Total Dividends | ₹1,355.00 | ₹140.00 |
| Ex-Dividend Date | Jul 25, 2025 | Jul 09, 2025 |